BioLargo, Inc. Discusses Commercial PFAS Treatment Trials and Garratt-Callahan Partnership with The Stock Day Podcast

Mar 09, 01:45 PM
The Stock Day Podcast welcomed BioLargo, Inc. (OTCQB:BLGO), a company that invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, air quality control, and infection control. President and CEO of BioLargo, Dennis P. Calvert, joined Stock Day host Everett Jolly.